Skip to search formSkip to main contentSkip to account menu

Cytogenetically Normal Acute Myeloid Leukemia

Known as: CN-AML, Normal Karyotype Acute Myeloid Leukemia 
Acute myeloid leukemia not associated with cytogenetic abnormalities.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Gain-of-function mutations of FLT3 (FLT3-ITD), comprises up to 30% of normal karyotype acute myeloid leukemia (AML) and is… 
2014
2014
Nucleophosmin 1 gene ( NPM1 ) mutations are found in approximately 50% of cytogenetically normal acute myeloid leukemia (CN-AML… 
2014
2014
Objective: This study aimed to assess the prognostic impact of Wilms tumor 1 (WT1) mutations in cytogenetically normal acute… 
2014
2014
BACKGROUND Nucleophosmin1 (NPM1) protein encoded from the NPM1 gene is a ubiquitously expressed nucleolar phoshoprotein which… 
2013
2013
MicroRNAs (miRNAs) are critical regulators of cellular processes such as differentiation and development, proliferation, and… 
2010
2010
Gastric cancer is the fourth most frequent type of cancer and the second cause of cancer mortality worldwide. The genetic… 
2009
2009
Purpose To determine the prognostic importance of the meningioma 1 (MN1) gene expression levels in the context of other… 
2009
2009
7001 Background: We showed recently that CEBPA mutations (mut) in CN AML are associated with better outcome and a unique microRNA… 
Review
2008
Review
2008
Acute myeloid leukemia (AML) represents a heterogeneous group of leukemia entities that differ with regard to biology, clinical… 
Review
2001
Review
2001
Editor—Dicentric autosomes are rarely encountered as stable constitutional chromosomes in humans, with the exception of…